Cargando…

HOW TO OPTIMALLY SEQUENCE AVAILABLE THERAPY LINES IN ADVANCED PROSTATE CANCER

Optimal sequencing of available therapy lines in patients with advanced prostate cancer often poses quite a challenge. The guidelines are sometimes equivocal and clinical trial data are not always applicable to a particular patient. There is a difference in availability of therapy options throughout...

Descripción completa

Detalles Bibliográficos
Autores principales:	Antunac, Katarina, Beketić-Orešković, Lidija
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sestre Milosrdnice University Hospital and Institute of Clinical Medical Research, Vinogradska cesta c. 29 Zagreb 2022
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022401/ https://www.ncbi.nlm.nih.gov/pubmed/36938556 http://dx.doi.org/10.20471/acc.2022.61.s3.5

Ejemplares similares

Correlation of High-Sensitivity Cardiac Troponin I Values and Cardiac Radiation Doses in Patients with Left-Sided Breast Cancer Undergoing Hypofractionated Adjuvant Radiotherapy with Concurrent Anti-HER2 Therapy
por: Antunac, Katarina, et al.
Publicado: (2023)

RADIOTHERAPY OF PROSTATE CANCER: PRIMARY RADIOTHERAPY AND RADIOTHERAPY IN DISEASE RELAPSE
por: Antunac, Katarina
Publicado: (2019)

FERTILITY PRESERVATION IN YOUNG WOMEN WITH EARLY-STAGE BREAST CANCER
por: Vuković, Petra, et al.
Publicado: (2019)

Possible predictive role of cancer/testis antigens in breast ductal carcinoma in situ
por: Roguljic, Ana, et al.
Publicado: (2018)

Optimal Sequencing and Predictive Biomarkers in Patients with Advanced Prostate Cancer
por: Cattrini, Carlo, et al.
Publicado: (2021)

Optimizing treatment selection and sequencing decisions for first-line maintenance therapy of newly diagnosed advanced ovarian cancer
por: Goh, Jeffrey C.H., et al.
Publicado: (2022)

Stable Gastric Pentadecapeptide BPC 157—Possible Novel Therapy of Glaucoma and Other Ocular Conditions
por: Sikiric, Predrag, et al.
Publicado: (2023)

MDR 1 activation is the predominant resistance mechanism selected by vinblastine in MES-SA cells
por: Chen, G K, et al.
Publicado: (2000)

Safety and efficacy of nivolumab as a second line therapy in metastatic renal cell carcinoma: a retrospective chart review
por: Gamulin, Marija, et al.
Publicado: (2020)

Optimizing the role of androgen deprivation therapy in advanced prostate cancer: Challenges beyond the guidelines
por: Shore, Neal D., et al.
Publicado: (2020)

Treatment of germ cell testicular cancer
por: Koši Kunac, Ana, et al.
Publicado: (2020)

Stomach perforation-induced general occlusion/occlusion-like syndrome and stable gastric pentadecapeptide BPC 157 therapy effect
por: Kalogjera, Luka, et al.
Publicado: (2023)

Advances in targeted alpha therapy for prostate cancer
por: De Vincentis, G, et al.
Publicado: (2019)

Innate Vascular Failure by Application of Neuroleptics, Amphetamine, and Domperidone Rapidly Induced Severe Occlusion/Occlusion-like Syndromes in Rats and Stable Gastric Pentadecapeptide BPC 157 as Therapy
por: Strbe, Sanja, et al.
Publicado: (2023)

Front-Line Maintenance Therapy in Advanced Ovarian Cancer—Current Advances and Perspectives
por: Reverdy, Thibaut, et al.
Publicado: (2020)

How to match the optimal currently available inhaler device to an individual child with asthma or recurrent wheeze
por: van Aalderen, Wim M, et al.
Publicado: (2015)

Active Surveillance in Prostate Cancer: Role of Available Biomarkers in Daily Practice
por: Pastor-Navarro, Belén, et al.
Publicado: (2021)

Recent advances in focal therapy of prostate and kidney cancer
por: Tsivian, Matvey, et al.
Publicado: (2010)

Enzalutamide therapy for advanced prostate cancer: efficacy, resistance and beyond
por: Linder, Simon, et al.
Publicado: (2018)

Tom Lawry. Hacking Healthcare: How AI and the Intelligence Revolution Will Reboot an Ailing System: Routledge. Taylor & Francis Group, A Productivity Press Book: 376 pages; hard copy. ISBN: 988-1-032-26016-7
por: Orešković, Stjepan
Publicado: (2022)

How valid are commercially available medical simulators?
por: Stunt, JJ, et al.
Publicado: (2014)

Treatment of pulmonary arterial hypertension: A review of drugs available for advanced therapy
por: Wilken, E, et al.
Publicado: (2019)

Next-generation Sequencing of Advanced Prostate Cancer Treated with Androgen-deprivation Therapy
por: Rajan, Prabhakar, et al.
Publicado: (2014)

How to Improve the Quality of Life of Patients with Prostate Cancer Treated with Hormone Therapy?
por: Turco, Fabio, et al.
Publicado: (2023)

Antiarrhythmic Sotalol, Occlusion/Occlusion-like Syndrome in Rats, and Stable Gastric Pentadecapeptide BPC 157 Therapy
por: Premuzic Mestrovic, Ivica, et al.
Publicado: (2023)

Recent advances on the progressive mechanism and therapy in castration-resistant prostate cancer
por: Wang, Keshan, et al.
Publicado: (2018)

Targeted Radiation and Immune Therapies—Advances and Opportunities for the Treatment of Prostate Cancer
por: Muralidhar, Anusha, et al.
Publicado: (2023)

Expectations and Challenges of First-Line Maintenance Therapy for Advanced Ovarian Cancer
por: Shoji, Tadahiro, et al.
Publicado: (2021)

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Advances and Treatment Strategies in the First-Line Setting
por: Ng, Kenrick, et al.
Publicado: (2020)

Hypoxia-induced therapy resistance: Available hypoxia-targeting strategies and current advances in head and neck cancer
por: Codony, Victoria L., et al.
Publicado: (2021)

Is there an optimal management for localized prostate cancer?
por: Singh, Jaspreet, et al.
Publicado: (2010)

Advances in prostate cancer imaging
por: Tangel, Matthew R., et al.
Publicado: (2018)

Pentadecapeptide BPC 157 as Therapy for Inferior Caval Vein Embolization: Recovery of Sodium Laurate-Post-Embolization Syndrome in Rats
por: Smoday, Ivan Maria, et al.
Publicado: (2023)

Articulating spacers: what are available and how to utilize them?
por: Li, Zhuo, et al.
Publicado: (2023)

Testosterone Therapy in Advanced Prostate Cancer
por: Chedrawe, Emily, et al.
Publicado: (2022)

Advances in Nanostructures for Antimicrobial Therapy
por: Jampilek, Josef, et al.
Publicado: (2022)

Stereotactic Ablative Brachytherapy: Recent Advances in Optimization of Radiobiological Cancer Therapy
por: Xue, Hui, et al.
Publicado: (2021)

Available evidence on HIFU for focal treatment of prostate cancer: a systematic review
por: Bakavicius, Arnas, et al.
Publicado: (2021)

Androgen Deprivation Therapy in High-Risk Localized and Locally Advanced Prostate Cancer
por: Iwamoto, Hiroaki, et al.
Publicado: (2022)

Androgen Deprivation Therapy, Hypogonadism and Cardiovascular Toxicity in Men with Advanced Prostate Cancer
por: Gheorghe, Gabriela Silvia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uvis94csm008ggojp38f0dqhns